Treatment patterns and outcomes for metastatic castration-resistant prostate cancer (mCRPC) in a real-world setting: A retrospective study of greater than 2500 patients.

被引：11
|
作者：
Higano, Celestia S.
Sternberg, Cora N.
Saad, Fred
Tombal, Bertrand F.
Miller, Kurt
Kalinovsky, Jan
Jiao, XiaoLong
Tangirala, Krishna
Sartor, A. Oliver
机构：
[1] Univ Washington, Seattle, WA 98195 USA
[2] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA
[3] Weill Cornell Med, Englander Inst Precis Med, New York, NY USA
[4] Univ Montreal, Ctr Hosp Univ Montreal, Montreal, PQ, Canada
[5] Clin Univ St Luc, Brussels, Belgium
[6] Charite, Dept Urol, Berlin, Germany
[7] Bayer Healthcare Pharmaceut Inc, Basel, Switzerland
[8] Bayer Healthcare Pharmaceut Inc, Whippany, NJ USA
[9] Tulane Med Sch, New Orleans, LA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 07期
关键词：
D O I：
10.1200/JCO.2019.37.7_suppl.256
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
256
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Real-world treatment patterns in French metastatic castration-resistant prostate cancer patients under abiraterone or enzalutamide
    Scailteux, L. M.
    Vincendeau, S.
    Gravis, G.
    Mathieu, R.
    Balusson, F.
    Kerbrat, S.
    Oger, E.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 10 - 11
  • [22] Treatment patterns of new metastatic castration-resistant prostate cancer (mCRPC) therapies: Real-world evidence from three datasets.
    Ellis, Lorie
    Lafeuille, Marie-Helene
    Gozalo, Laurence
    Lefebvre, Patrick
    Malangone-Monaco, Elisabetta
    Wilson, Kathleen
    Foley, Kathleen A.
    McKenzie, R. Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [23] Enzalutamide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: A retrospective Korean multicenter study in a real-world setting
    Jung, Seung Il
    Kim, Myung Soo
    Jeong, Chang Wook
    Kwak, Cheol
    Hong, Sung Kyu
    Kang, Seok Ho
    Joung, Jae Young
    Lee, Seung Hwan
    Yun, Seok Joong
    Kim, Tae-Hwan
    Park, Sung Woo
    Jeon, Seong Soo
    Kang, Minyong
    Lee, Ji Youl
    Chung, Byung Ha
    Hong, Jun Hyuk
    Ahn, Hanjong
    Kim, Choung-Soo
    Kwon, Dong Deuk
    INVESTIGATIVE AND CLINICAL UROLOGY, 2020, 61 (01) : 19 - 27
  • [24] Real-world treatment patterns and overall survival among men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) in the US Medicare population
    Freedland, Stephen J.
    Davis, Matthew
    Epstein, Andrew J.
    Arondekar, Bhakti
    Ivanova, Jasmina I.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2024, 27 (02) : 327 - 333
  • [25] Real-world treatment patterns and overall survival among men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) in the US Medicare population
    Stephen J. Freedland
    Matthew Davis
    Andrew J. Epstein
    Bhakti Arondekar
    Jasmina I. Ivanova
    Prostate Cancer and Prostatic Diseases, 2024, 27 : 327 - 333
  • [26] Real-world treatment (Tx) patterns in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC) and homologous recombination repair mutations (HRRm plus )
    Shore, N.
    Ionescu-Ittu, R.
    Laliberte, F.
    Yang, L.
    Gayle, A.
    Payne, S.
    Mahendran, M.
    Amin, S.
    Lejeune, D.
    Burgents, J. E.
    Duh, M. S.
    Yu, L.
    Ghate, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S531 - S532
  • [27] Real-World Overall Survival and Treatment Patterns by PTEN Status in Metastatic Castration-Resistant Prostate Cancer
    Gupta, Shilpa
    To, Tu My
    Graf, Ryon
    Kadel, Edward E.
    Reilly, Norelle
    Albarmawi, Husam
    JCO PRECISION ONCOLOGY, 2024, 8
  • [28] Real-World Outcomes in First-Line Treatment of Metastatic Castration-Resistant Prostate Cancer: The Prostate Cancer Registry
    Simon Chowdhury
    Anders Bjartell
    Nicolaas Lumen
    Pablo Maroto
    Thomas Paiss
    Francisco Gomez-Veiga
    Alison Birtle
    Gero Kramer
    Ewa Kalinka
    Dominique Spaëth
    Susan Feyerabend
    Vsevolod Matveev
    Florence Lefresne
    Martin Lukac
    Robert Wapenaar
    Luis Costa
    Targeted Oncology, 2020, 15 : 301 - 315
  • [29] REAL-WORLD DATA ANALYSIS OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) TREATMENT DECISIONS WITH THE INTRODUCTION OF NEWER TREATMENT OPTIONS
    Scott, J.
    Concepcion, R.
    Garofalo, D.
    Verma-Kurvari, S.
    Xu, B.
    Montgomery, J.
    VALUE IN HEALTH, 2018, 21 : S43 - S43
  • [30] Real-World Outcomes in First-Line Treatment of Metastatic Castration-Resistant Prostate Cancer: The Prostate Cancer Registry
    Chowdhury, Simon
    Bjartell, Anders
    Lumen, Nicolaas
    Maroto, Pablo
    Paiss, Thomas
    Gomez-Veiga, Francisco
    Birtle, Alison
    Kramer, Gero
    Kalinka, Ewa
    Spaeth, Dominique
    Feyerabend, Susan
    Matveev, Vsevolod
    Lefresne, Florence
    Lukac, Martin
    Wapenaarls, Robert
    Costa, Luis
    TARGETED ONCOLOGY, 2020, 15 (03) : 301 - 315
12345